BLUEBIRD BIO INC (BLUE) Stock Balance Sheet
NASDAQ:BLUE - Nasdaq - US09609G1004 - Common Stock
| MRQ (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 70.65M | 221.75M | 113.00M | 161.20M | 317.70M | |||
| Marketable Securities | N/A | 0.00 | 67.30M | 138.30M | 833.50M | |||
| Receivables | 1.06M | N/A | N/A | N/A | 400.00K | |||
| Inventories | 53.94M | 22.92M | N/A | 0.00 | N/A | |||
| Other Current Assets | 25.15M | 37.01M | 19.20M | 37.00M | 63.90M | |||
| Total Current Assets | 150.81M | 281.69M | 199.50M | 336.50M | 1.22B | |||
| Non-Current Assets | ||||||||
| PPE Net | 245.69M | 267.05M | 291.40M | 101.20M | 346.90M | |||
| Investments And Advances | N/A | 0.00 | 1.40M | 97.10M | 122.90M | |||
| Goodwill | 5.65M | 5.65M | 5.60M | 5.60M | 13.10M | |||
| Intangibles | 9.78M | 10.44M | 4.90M | 0.00 | 10.00M | |||
| Other Non-Current Assets | 53.13M | 54.34M | 52.10M | 53.30M | 72.80M | |||
| Total Non-Current Assets | 314.25M | 337.48M | 355.40M | 257.30M | 565.80M | |||
| TOTAL ASSETS | 465.06M | 619.16M | 554.90M | 593.80M | 1.78B | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 166.78M | 84.70M | N/A | N/A | N/A | |||
| Accrued Expenses | 87.50M | 88.79M | 100.90M | 123.70M | 149.80M | |||
| Accounts Payable | 24.48M | 18.50M | 25.10M | 25.90M | 21.60M | |||
| Other Current Liabilities | 17.27M | 8.12M | 2.30M | 3.40M | 32.20M | |||
| Total Current Liabilities | 296.03M | 200.11M | 128.20M | 153.00M | 203.60M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 5.67M | 37.73M | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 169.13M | 186.78M | 230.30M | 66.50M | 222.60M | |||
| Total Non-Current Liabilities | 174.81M | 224.51M | 230.40M | 66.50M | 222.60M | |||
| TOTAL LIABILITIES | 470.84M | 424.62M | 358.60M | 219.50M | 426.20M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -4.47B | -4.26B | -3.99B | -3.72B | -2.90B | |||
| Additional Paid In Capital | 4.47B | 4.45B | 4.19B | 4.10B | 4.26B | |||
| Common Shares | 1.92M | 1.91M | 800.00K | 700.00K | 700.00K | |||
| Other Shareholders' Equity | -1.51M | -1.80M | -4.10M | -2.90M | -5.50M | |||
| Shares Outstanding | 9.70M | 9.64M | 82.90M | 71.10M | 66.40M | |||
| Tangible Book Value per Share | -2.19 | 18.51 | 2.24 | 5.19 | 20.06 | |||
| Total Shareholders' Equity | -5.79M | 194.54M | 196.30M | 374.30M | 1.36B | |||
| TOTAL LIABILITIES AND EQUITY | 465.06M | 619.16M | 554.90M | 593.80M | 1.78B | |||
| Statistics | ||||||||
| Debt/Equity | -0.98 | 0.19 | N/A | N/A | N/A | |||
| Current Ratio | 0.51 | 1.41 | 1.56 | 2.20 | 5.97 | |||
| Return On Assets (ROA) | -64.62% | -34.23% | -48.04% | -137.99% | -34.73% | |||
| Return On Equity (ROE) | N/A | -108.93% | -135.80% | -218.91% | -45.66% | |||
All data in USD , ROIC based on taxRate of 0.21